Australia Stock Exchange release from NEUROSCIENTIFIC : Initial Director's Interest Notice
Australia Stock Exchange release from NEUROSCIENTIFIC NSB.AX : Initial Director's Interest Notice
Recent news on Neuroscientific Biopharmaceuticals
See all newsBrief: Neuroscientific Biopharmaceuticals Appoints Chris Knee As CFO
Brief: Neuroscientific Biopharmaceuticals Seeks Trading Halt
Australia's NeuroScientific Biopharmaceuticals surges on positive clinical results
Brief: Neuroscientific Biopharmaceuticals Requests Trading Halt
Brief: Neuroscientific Biopharmaceuticals Appoints Nathan Smith As CEO